Evidence map›Paper›PMID 32852324›Full record

ArticleObstetrics and gynecology2020

High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19).

Bijan Safaee Fakhr, Steffen B Wiegand, Riccardo Pinciroli, Stefano Gianni, Caio C A Morais, Takamitsu Ikeda, Yusuke Miyazaki, Eizo Marutani, Raffaele Di Fenza, Grant M Larson and 12 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Obstetrics and gynecology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05612074 (Kinetics of Methemoglobin Concentration in Healthy Subjects Exposed to High Dose Inhaled Nitric Oxide), which is not on this map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05612074 early_phase1active not recruitingnot on this mapstarted 2023, after this paper: background citation

Kinetics of Methemoglobin Concentration in Healthy Subjects Exposed to High Dose Inhaled Nitric Oxide

TypeinterventionalSponsorMassachusetts General HospitalRan2023 to 2027Enrolled10ConditionsHealthy SubjectsArmsInhaled Nitric Oxide
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Managing Respiratory Failure in Late Pregnancy.Journal of clinical medicine · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Epoprostenol Exposure During Pregnancy.Critical care explorations · 2023
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Utility of NO and HNitric oxide : biology and chemistry · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Bijan Safaee FakhrDepartment of Anesthesia, the Department of Pediatrics, the Respiratory Care Department, the Department of Obstetrics and Gynecology, and the Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts; and the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Steffen B Wiegand
Riccardo Pinciroli
Stefano Gianni
Caio C A Morais
Takamitsu Ikeda
Yusuke Miyazaki
Eizo Marutani
Raffaele Di Fenza
Grant M Larson
Vibhu Parcha
Lauren E Gibson
Marvin G Chang
Pankaj Arora
Ryan W Carroll
Robert M Kacmarek
Fumito Ichinose
William H Barth
Anjali Kaimal
Elizabeth L Hohmann
Warren M Zapol
Lorenzo Berra
University of Alabama at Birmingham Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRescue therapies to treat or prevent progression of coronavirus disease 2019 (COVID-19) hypoxic respiratory failure in pregnant patients are lacking.

methodTo treat pregnant patients meeting criteria for severe or critical COVID-19 with high-dose (160-200 ppm) nitric oxide by mask twice daily and report on their clinical response. EXPERIENCE: Six pregnant patients were admitted with severe or critical COVID-19 at Massachusetts General Hospital from April to June 2020 and received inhalational nitric oxide therapy. All patients tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A total of 39 treatments was administered. An improvement in cardiopulmonary function was observed after commencing nitric oxide gas, as evidenced by an increase in systemic oxygenation in each administration session among those with evidence of baseline hypoxemia and reduction of tachypnea in all patients in each session. Three patients delivered a total of four neonates during hospitalization. At 28-day follow-up, all three patients were home and their newborns were in good condition. Three of the six patients remain pregnant after hospital discharge. Five patients had two negative test results on nasopharyngeal swab for SARS-CoV-2 within 28 days from admission.

conclusionNitric oxide at 160-200 ppm is easy to use, appears to be well tolerated, and might be of benefit in pregnant patients with COVID-19 with hypoxic respiratory failure.

Indexed as

Administration, InhalationBetacoronavirusCoronavirus InfectionsCOVID-19FemaleHumansMassachusettsNitric OxidePandemicsPneumonia, ViralPregnancyPregnancy Complications, InfectiousSARS-CoV-2Treatment OutcomeNitric Oxide

Identifiers

PMID32852324
PMCPMC7673637
OpenAlexW3081179290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.